Ian Kavanagh

Company: Apis Assay Technologies Ltd

Job title: Chief Operating Officer

Seminars:

Development of a Novel Breast Cancer Subtyping and Proliferation Gene Expression Diagnostic Test 9:30 am

• A RT-qPCR nucleic acid-based CE-IVD test for the detection and relative gene expression quantification of human mRNA target genes from pre-operative CNB or resected FFPE breast tumour tissue from patients with invasive breast cancer • Breast cancer subtyping performance of the CE-IVD test is determined by concordance to that assigned by the current histopathology…Read more

day: Day Two Morning